Stifel Financial Corp Repare Therapeutics Inc. Transaction History
Stifel Financial Corp
- $91.8 Billion
- Q1 2025
A detailed history of Stifel Financial Corp transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 80,600 shares of RPTX stock, worth $107,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,600
Previous 89,500
9.94%
Holding current value
$107,198
Previous $117,000
32.48%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPTX
# of Institutions
53Shares Held
32.2MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$13.7 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.58 Million1.76% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.42 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.95 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.52 Million5.46% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $55.8M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...